LeMaitre Vascular (NASDAQ:LMAT) Upgraded by Barrington Research to Outperform Rating

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was upgraded by stock analysts at Barrington Research from a “market perform” rating to an “outperform” rating in a research report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a $9…

Read Full Article →